Showing results (121-130 of 307) with videos related to

Sort By:
Pageof 31
Plos One|November 7, 2015
Nasal Levels of Antimicrobial Peptides in Allergic Asthma Patients and Healthy Controls: Differences and Effect of a Short 1,25(OH)2 Vitamin D3 TreatmentWillemien Thijs, Kirsten Janssen, Annemarie M van Schadewijk, et al.
Bone|November 19, 2003
Determinants of induction and duration of remission of Paget's disease of bone after bisphosphonate (olpadronate) therapyMarelise E M W Eekhoff, Aeilko H Zwinderman, Dorien M A D Haverkort, et al.
Endocrinology|November 13, 2004
Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growthStuart J Warden, Alexander G Robling, Megan S Sanders, et al.
Alcoholism, Clinical and Experimental Research|November 5, 2005
Bone mass and strength: phenotypic and genetic relationship to alcohol preference in P/NP and HAD/LAD ratsImranul Alam, Alexander G Robling, Sarah Weissing, et al.
Endocrinology|March 19, 2002
Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor AMartine M L Deckers, Rutger L van Bezooijen, Geertje van der Horst, et al.
Archives of Biochemistry and Biophysics|September 3, 2008
Cargo-sorting signals promote polymerization of adaptor protein-1 in an Arf-1.GTP-independent mannerIntaek Lee, Matthew T Drake, Linton M Traub, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 26, 2020
Generation and Characterization of Mouse Models for Skeletal DiseaseGabrielle E Foxa, Ye Liu, Lisa M Turner, et al.
Bone|February 28, 2012
Acute phase response following intravenous zoledronate in postmenopausal women with low bone massAthanasios D Anastasilakis, Stergios A Polyzos, Polyzois Makras, et al.
The Journal of Rheumatology|September 1, 2004
Short term whole body retention in relation to rate of bone resorption and cartilage degradation after intravenous bisphosphonate (pamidronate) in rheumatoid arthritisSerge C L M Cremers, Mariëtte C Lodder, Jan Den Hartigh, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 27, 2002
Strontium-89 (Metastron) and the bisphosphonate olpadronate reduce the incidence of spinal cord compression in patients with hormone-refractory prostate cancer metastatic to the skeletonVidya Soerdjbalie-Maikoe, Rob C M Pelger, Guus A B Lycklama à Nijeholt, et al.
Pageof 31